Ray Dalio's position in Abbvie is currently worth $82.6 Million. That's 0.48% of their equity portfolio (42nd largest holding). The first Abbvie trade was made in Q4 2020. Since then Ray Dalio bought shares seven more times and sold shares on four occasions. The investor's estimated purchase price is $84.1 Million, resulting in a loss of 1.8%.